BIOLIFE SOLUTIONS INC — Director's Dealing 2021

Apr 15, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-04-12

Reporting Person: Mathew Aby J. (Exec VP & Chief Scientific Off)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-12	Common Stock	A	3360	—	Acquired	210679	Direct

Footnotes

F1: The restricted stock award was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests in six (6) months.

F2: The amount reported in Column 5 on Table I in the Form 4 filed by the reporting person on April 1, 2021 was incorrect by a deficit of 6,338 due to a typographical error.